We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

39 hedge funds and large institutions have $86.6M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,050% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 2

117% more funds holding

Funds holding: 18 → 39 (+21)

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

92% more capital invested

Capital invested by funds: $45.1M → $86.6M (+$41.5M)

Holders
39
Holders Change
+21
Holders Change %
+116.67%
% of All Funds
0.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
4
Reduced
2
Closed
2
Calls
$200K
Puts
–
Net Calls
+$200K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
GL
Governors Lane
New York
+$4.86M
2
PC
Periscope Capital
Ontario, Canada
+$3.98M
3
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$3.72M
4
SCM
Shaolin Capital Management
Florida
+$3.47M
5
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
+$2.98M

Top Sellers

Rank Fund Capital Flow
1
OCM
Oaktree Capital Management
California
-$2.5M
2
FLC
Fifth Lane Capital
Texas
-$986K
3
WAM
Wolverine Asset Management
Illinois
-$784K
4
SV
Starboard Value
New York
-$61K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
Beryl Capital Management
California
$9.94M – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$7.46M – – –
SCM
3
Saba Capital Management
New York
$5.72M +$404K +40,739 +8%
GL
4
Governors Lane
New York
$4.88M +$4.86M +490,000 New
SC
5
Sculptor Capital
New York
$4.3M +$2.54M +256,158 +146%
PC
6
Periscope Capital
Ontario, Canada
$4M +$3.98M +401,300 New
Balyasny Asset Management
7
Balyasny Asset Management
Illinois
$3.74M – – –
PMAM
8
Picton Mahoney Asset Management
Ontario, Canada
$3.74M +$3.72M +375,000 New
SCM
9
Shaolin Capital Management
Florida
$3.49M +$3.47M +350,000 New
Toronto Dominion Bank
10
Toronto Dominion Bank
Ontario, Canada
$2.99M +$2.98M +300,000 New
CSS
11
Cubist Systematic Strategies
Connecticut
$2.56M +$2.55M +256,557 New
Goldman Sachs
12
Goldman Sachs
New York
$2.56M +$2.55M +256,887 New
TCM
13
Tenor Capital Management
New York
$2.5M +$2.48M +250,000 New
LA
14
Linden Advisors
New York
$2.49M +$2.48M +250,000 New
WAM
15
Wolverine Asset Management
Illinois
$2.3M -$784K -78,978 -26%
CCM
16
Context Capital Management
California
$2.25M +$2.23M +225,000 New
WRBC
17
W.R. Berkley Corp
Connecticut
$2.07M – – –
CH
18
CVI Holdings
Delaware
$2M +$75K +7,555 +4%
AIMCA
19
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2M +$1.99M +200,000 New
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$2M +$1.99M +200,000 New
BCM
21
Basso Capital Management
Connecticut
$2M – – –
WCMNY
22
Westchester Capital Management (New York)
New York
$1.99M +$1.98M +199,900 New
AA
23
AQR Arbitrage
Connecticut
$1.51M +$1.51M +151,896 New
FTCM
24
Fir Tree Capital Management
New York
$1.5M – – –
RCM
25
Radcliffe Capital Management
Pennsylvania
$1.27M +$271K +27,269 +27%
1
2

LVAC Hedge Fund Activity: Q1 2022 in Review

39 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2022, worth a combined $86.6M — up 92% from $45.1M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LVAC positions and 2 closed out — a net gain of 21 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Governors Lane, opening a new position worth an estimated $4.86M. The largest seller was Oaktree Capital Management, exiting entirely with an estimated $2.5M sold.

  • 39 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2022, up from 18 in Q4 2021.
  • Funds reported $86.6M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2022, up 92% quarter-over-quarter.
  • 23 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2022 and 2 closed out, a net change of +21 holders.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2022 was Governors Lane, an estimated $4.86M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2022 was Oaktree Capital Management, an estimated $2.5M sold.

Based on aggregated 13F filings for Q1 2022.